Skip to Main Content

Advertisement

Skip Nav Destination

First Edition

Research Article September 20 2023
Integrated Epigenetic and Transcriptional Single-Cell Analysis of t(11;14) Multiple Myeloma and Its BCL2 Dependency
Review Article September 20 2023
Moving towards disease modification in polycythemia vera
Research Article September 13 2023
How I treat secondary CNS involvement by aggressive lymphomas
Letter September 13 2023
Splenic iron decreases without change in volume or liver parameters during luspatercept therapy
Research Article September 12 2023
Spatial Transcriptomics Reveals Distinct Tissue Niches Linked with Steroid Responsiveness in Acute Gastrointestinal GVHD
Research Article September 12 2023
Neutral sphingomyelinase blockade enhances hematopoietic stem cell fitness through an integrated stress response
Research Article September 12 2023
Hemostasis defects underlying the hemorrhagic syndrome caused by Mammarenaviruses in a cynomolgus macaque model
Research Article September 8 2023
Alternative splicing of its 5' UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies
Research Article September 8 2023
Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B cell receptor
Research Article September 8 2023
Hemostasis without clot formation - how platelets guard the vasculature in inflammation, infection, and malignancy
Research Article September 6 2023
How I treat von Willebrand disorders in the elderly
Research Article August 30 2023
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML:a randomized, placebo-controlled study by the ALLG
Brief Report August 30 2023
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based non-intensive therapy
Research Article August 30 2023
The effects of pathogenic variants for inherited hemostasis disorders in 140,214 UK Biobank participants
Research Article August 30 2023
A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease
Brief Report August 30 2023
CD19/CD22 targeting with co-transduced CAR T-cells to prevent antigen negative relapse after CAR T-cell therapy of B-ALL
Research Article August 30 2023
A signature of platelet reactivity in CBC scattergrams reveals genetic predictors of thrombotic disease risk
Letter August 30 2023
TP53 status and impact on AML prognosis within the ELN 2022 risk classification
Research Article August 30 2023
How I treat transplant-eligible patients with myelofibrosis
Research Article August 25 2023
Oncogene-induced MALT1 protease activity drives post-transcriptional gene expression in malignant lymphomas
Review Article August 25 2023
Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide & CRISPR-Cas9 treatments
Research Article August 25 2023
Early B cell development and B cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis
Research Article August 25 2023
The iron chaperone poly C binding protein 1 regulates iron efflux through intestinal ferroportin in mice
Letter August 25 2023
Identifying STRN3-RARA as a new fusion gene for acute promyelocytic leukemia
Research Article August 25 2023
The oxylipin analogue CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor
Research Article August 24 2023
Exploiting the CD200-CD200R Immune Checkpoint Axis in Multiple Myeloma to Enhance CAR-T Therapy
Research Article August 24 2023
Modulation of Human Thrombopoietin Receptor Conformations Uncouples JAK2 V617F-Driven From Cytokine-Induced Activation
Research Article August 24 2023
Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress
Brief Report August 24 2023
Lineage-specific detection of residual disease predicts relapse in chronic myeloid leukemia patients stopping therapy
Research Article August 18 2023
Targeting cancer hallmark vulnerabilities in hematologic malignancies by interfering with Hedgehog/GLI signaling
Brief Report August 18 2023
Sustained remissions in CLL after frontline FCR treatment with very long-term follow-up
Review Article August 18 2023
Macrophage heterogeneity in the single cell era: facts and artefacts
Research Article August 18 2023
Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: Incidence, clinical characteristics and survival
Research Article August 18 2023
Genome-wide Transcription Factor binding maps reveal cell-specific changes in the regulatory architecture of human HSPC
Letter August 18 2023
BRAFV600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis
Research Article August 18 2023
Genetic alterations and MRD refine risk assessment within KMT2A-rearranged B-cell precursor ALL in adult: a GRAALL study
Research Article August 18 2023
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy
Research Article August 18 2023
Fractionated Versus Single Dose Gemtuzumab Ozogamicin with Determinants of Benefit in Older AML: UK NCRI AML18 Trial
Research Article August 15 2023
LepR+ niche cell-derived AREG compromises hematopoietic stem cell maintenance under conditions of DNA repair deficiency and aging
Research Article August 10 2023
Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as predictor of mortality in children
Research Article August 10 2023
Loss of endothelial membrane KIT Ligand affects systemic KIT ligand levels but not bone marrow hematopoietic stem cells
Research Article August 10 2023
Genotype, Oxidase Status, and Preceding Infection or Autoinflammation Do Not Affect Allogeneic HCT Outcomes for CGD
Review Article August 10 2023
The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes
Research Article August 10 2023
CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma
Research Article August 9 2023
Prognostic Significance of ETP Phenotype and Minimal Residual Disease in T-ALL: A Children's Oncology Group Study
Research Article August 4 2023
How I Treat Post-Transplant Lymphoproliferative Disorder
Discussion August 4 2023
Mitigating inequity: ethically prioritizing patients to CAR T-cell therapy
Letter July 31 2023
Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis
Research Article July 28 2023
LENALIDOMIDE AND DEXAMETHASONE WITH OR WITHOUT IXAZOMIB MAINTENANCE TAILORED BY RESIDUAL DISEASE STATUS IN MYELOMA
Research Article July 28 2023
Low Density Lipoprotein promotes Microvascular Thrombosis by enhancing von Willebrand Factor Self-association
Page 1 of 2
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement